id: NEW:cirrhosis_to_liver_disease_mortality
name: Cirrhosis â†’ Liver Disease Mortality
from_node:
  node_id: NEW:cirrhosis
  node_name: Cirrhosis
to_node:
  node_id: liver_disease_mortality
  node_name: Liver Disease Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Cirrhosis causes progressive liver fibrosis and architectural distortion,
  leading to portal hypertension and hepatocellular dysfunction'
- 'Step 2: Portal hypertension leads to development of complications including ascites
  (median survival 1.1 years), hepatic encephalopathy (median survival 0.92 years),
  variceal bleeding, and hepatorenal syndrome (median survival <2 weeks)'
- 'Step 3: Cirrhosis increases risk of hepatocellular carcinoma (1-4% annual incidence)
  with 5-year survival of approximately 20%'
- 'Step 4: Decompensated cirrhosis with multiple complications leads to progressive
  multi-organ failure and death from liver disease'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'E. Tapper and N. Parikh 2023. Diagnosis and Management of Cirrhosis
    and Its Complications: A Review. Journal of the American Medical Association (JAMA)'
  supporting_citations: []
description: Cirrhosis directly causes liver disease mortality through progressive
  hepatocellular dysfunction and portal hypertension, leading to life-threatening
  complications. Age-adjusted mortality from cirrhosis increased from 14.9 to 21.9
  per 100,000 between 2010-2021. Median survival following onset of ascites is 1.1
  years and hepatic encephalopathy is 0.92 years. Hepatorenal syndrome carries median
  survival of less than 2 weeks. Annual hepatocellular carcinoma incidence of 1-4%
  with 5-year survival of approximately 20% further contributes to mortality.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: decompensation_status
  direction: strengthens
  strength: strong
  description: Approximately 40% of cirrhosis patients are diagnosed at decompensation;
    onset of hepatic encephalopathy or ascites dramatically reduces survival to less
    than 1-2 years
- name: etiology
  direction: strengthens
  strength: moderate
  description: Alcohol use disorder (45%), nonalcoholic fatty liver disease (26%),
    and hepatitis C (41%) are major causes that may overlap and influence progression
- name: hepatocellular_carcinoma_development
  direction: strengthens
  strength: strong
  description: Annual HCC incidence of 1-4% with 5-year survival of approximately
    20% significantly increases mortality risk
